Induced Changes in Ventilatory Responsiveness and Altitude Exposure
Modulation of Oxygen Sensor Reactivity to Mimic Altitude Acclimatization
Sponsor: United States Army Research Institute of Environmental Medicine
Terminated
Results of preliminary analyses showed no reason to continue the study
Listed as NCT01241513, this PHASE4 trial focuses on Abnormal Blood Oxygen Pressure and Effects of High Altitude and remains terminated or withdrawn. Sponsored by United States Army Research Institute of Environmental Medicine, it has been updated 10 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
May 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — May 2020 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- United States Army Research Institute of Environmental Medicine
For direct contact, visit the study record on ClinicalTrials.gov .